Enzon Pharmaceuticals, Inc. (ENZN) Misses Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts ENZN Hot Sheet
Price: $4.35 --0%
Financial Fact:
General and administrative: 146K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
General and administrative: 146K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q2 loss of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $9.6 million versus the consensus estimate of $15.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
